Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China
Abstract Objective This study aims to evaluate the relationship between apolipoproteins (ApoA1, ApoB, and the ApoB/A1 ratio) and the incidence of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and impaired kidney function, assessing their potential role in...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Nutrition Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12937-025-01078-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832595017722494976 |
|---|---|
| author | Zixiang Ye Enmin Xie Zhangyu Lin Chenxi Song Rui zhang Haoyu Wang Yongbao Zhang Kefei Dou |
| author_facet | Zixiang Ye Enmin Xie Zhangyu Lin Chenxi Song Rui zhang Haoyu Wang Yongbao Zhang Kefei Dou |
| author_sort | Zixiang Ye |
| collection | DOAJ |
| description | Abstract Objective This study aims to evaluate the relationship between apolipoproteins (ApoA1, ApoB, and the ApoB/A1 ratio) and the incidence of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and impaired kidney function, assessing their potential role in secondary prevention. Method A prospective cohort of 1,640 patients with impaired kidney function who underwent percutaneous coronary intervention in China was analyzed. Patients were categorized based on the measurements of ApoA1, ApoB, and ApoB/A1 ratio. MACE, defined as a composite of all-cause mortality, cardiovascular death, nonfatal myocardial infarctions, strokes, and unplanned revascularizations, was tracked post-procedure, with statistical analyses including Kaplan–Meier survival curves and Cox regression models to identify associations with apolipoproteins. Subgroup analyses according to kidney function were conducted. Result During a median follow-up of 3.1 years, 324 MACE events were observed. Multivariable Cox regression analyses illustrated higher levels of ApoB and the ApoB/A1 ratio were significantly associated with increased MACE incidence (adjusted HR [95%CI] 1.668[1.044–2.666]; adjusted HR [95%CI] 2.231[1.409–3.533], respectively), while lower ApoA1 levels correlated with a higher risk (adjusted HR [95%CI] 0.505[0.326–0.782]). ROC curve analyses indicated comparable predictive performances to traditional risk factors like LDL cholesterol. Subgroup analysis revealed that the above association was not statistically significant in the moderate-to-severe renal impairment CAD patients (eGFR < 45 mL/min/1.73 m2). Conclusion Our findings illustrate that apolipoproteins, specifically ApoA1 and ApoB, along with their ratio, are significant predictors of major adverse cardiovascular events in CAD patients with impaired kidney function. These results emphasize the need for incorporating apolipoprotein measurements in secondary prevention strategies for this high-risk population. |
| format | Article |
| id | doaj-art-fe37f997d7d0431da3d81848d3ff2cf7 |
| institution | Kabale University |
| issn | 1475-2891 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Nutrition Journal |
| spelling | doaj-art-fe37f997d7d0431da3d81848d3ff2cf72025-01-19T12:11:17ZengBMCNutrition Journal1475-28912025-01-0124111110.1186/s12937-025-01078-9Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in ChinaZixiang Ye0Enmin Xie1Zhangyu Lin2Chenxi Song3Rui zhang4Haoyu Wang5Yongbao Zhang6Kefei Dou7Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAortic and Vascular Surgery Centre, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Centre for Cardiovascular DiseasesDepartment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Objective This study aims to evaluate the relationship between apolipoproteins (ApoA1, ApoB, and the ApoB/A1 ratio) and the incidence of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and impaired kidney function, assessing their potential role in secondary prevention. Method A prospective cohort of 1,640 patients with impaired kidney function who underwent percutaneous coronary intervention in China was analyzed. Patients were categorized based on the measurements of ApoA1, ApoB, and ApoB/A1 ratio. MACE, defined as a composite of all-cause mortality, cardiovascular death, nonfatal myocardial infarctions, strokes, and unplanned revascularizations, was tracked post-procedure, with statistical analyses including Kaplan–Meier survival curves and Cox regression models to identify associations with apolipoproteins. Subgroup analyses according to kidney function were conducted. Result During a median follow-up of 3.1 years, 324 MACE events were observed. Multivariable Cox regression analyses illustrated higher levels of ApoB and the ApoB/A1 ratio were significantly associated with increased MACE incidence (adjusted HR [95%CI] 1.668[1.044–2.666]; adjusted HR [95%CI] 2.231[1.409–3.533], respectively), while lower ApoA1 levels correlated with a higher risk (adjusted HR [95%CI] 0.505[0.326–0.782]). ROC curve analyses indicated comparable predictive performances to traditional risk factors like LDL cholesterol. Subgroup analysis revealed that the above association was not statistically significant in the moderate-to-severe renal impairment CAD patients (eGFR < 45 mL/min/1.73 m2). Conclusion Our findings illustrate that apolipoproteins, specifically ApoA1 and ApoB, along with their ratio, are significant predictors of major adverse cardiovascular events in CAD patients with impaired kidney function. These results emphasize the need for incorporating apolipoprotein measurements in secondary prevention strategies for this high-risk population.https://doi.org/10.1186/s12937-025-01078-9ApolipoproteinImpaired kidney functionCoronary artery diseaseMajor adverse cardiovascular eventsSecondary prevention |
| spellingShingle | Zixiang Ye Enmin Xie Zhangyu Lin Chenxi Song Rui zhang Haoyu Wang Yongbao Zhang Kefei Dou Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China Nutrition Journal Apolipoprotein Impaired kidney function Coronary artery disease Major adverse cardiovascular events Secondary prevention |
| title | Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China |
| title_full | Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China |
| title_fullStr | Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China |
| title_full_unstemmed | Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China |
| title_short | Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China |
| title_sort | validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis a prospective cohort study in china |
| topic | Apolipoprotein Impaired kidney function Coronary artery disease Major adverse cardiovascular events Secondary prevention |
| url | https://doi.org/10.1186/s12937-025-01078-9 |
| work_keys_str_mv | AT zixiangye validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina AT enminxie validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina AT zhangyulin validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina AT chenxisong validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina AT ruizhang validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina AT haoyuwang validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina AT yongbaozhang validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina AT kefeidou validationoftheroleofapolipoproteinsincoronaryarterydiseasepatientswithimpairedkidneyfunctionforprognosisaprospectivecohortstudyinchina |